Colorectal Cancer Therapeutics

Colorectal Cancer Therapeutics

Colorectal Cancer Therapeutics market worldwide is projected to grow by US$1.4 Billion, driven by a compounded growth of 2.1%. Chemotherapy, one of the segments analyzed and sized in this study, displays the potential to grow at over 2.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$2.5 Billion by the year 2025, Chemotherapy will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 1.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$53.8 Million to the region's size and clout in the next 5 to 6 years. Over US$40.9 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Chemotherapy will reach a market size of US$113.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 3.3% over the next couple of years and add approximately US$370.7 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include among others, Amgen, Inc.; Bayer AG; F. Hoffmann-La Roche AG; Merck KGaA; Novartis International AG; Spectrum Pharmaceuticals

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Colorectal Cancer Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Colorectal Cancer Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 2: Colorectal Cancer Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
TABLE 3: Colorectal Cancer Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
TABLE 4: Chemotherapy (Treatment) World Market by Region/Country in US$ Million: 2018 to 2025
TABLE 5: Chemotherapy (Treatment) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
TABLE 6: Chemotherapy (Treatment) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 7: Targeted Therapy (Treatment) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
TABLE 8: Targeted Therapy (Treatment) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
TABLE 9: Targeted Therapy (Treatment) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
TABLE 10: Immunotherapy (Treatment) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
TABLE 11: Immunotherapy (Treatment) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
TABLE 12: Immunotherapy (Treatment) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 13: Other Treatments (Treatment) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
TABLE 14: Other Treatments (Treatment) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
TABLE 15: Other Treatments (Treatment) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
TABLE 16: Colonoscopy (Diagnostic) World Market by Region/Country in US$ Million: 2018 to 2025
TABLE 17: Colonoscopy (Diagnostic) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
TABLE 18: Colonoscopy (Diagnostic) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 19: Biopsy (Diagnostic) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
TABLE 20: Biopsy (Diagnostic) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
TABLE 21: Biopsy (Diagnostic) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
TABLE 22: Molecular Testing of Tumor (Diagnostic) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025
TABLE 23: Molecular Testing of Tumor (Diagnostic) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017
TABLE 24: Molecular Testing of Tumor (Diagnostic) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 25: Positron Emission Tomography Scan (Diagnostic) World Market by Region/Country in US$ Million: 2018 to 2025
TABLE 26: Positron Emission Tomography Scan (Diagnostic) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
TABLE 27: Positron Emission Tomography Scan (Diagnostic) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 28: Digital Rectal Examination (Diagnostic) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
TABLE 29: Digital Rectal Examination (Diagnostic) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
TABLE 30: Digital Rectal Examination (Diagnostic) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
TABLE 31: Other Diagnostics (Diagnostic) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
TABLE 32: Other Diagnostics (Diagnostic) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
TABLE 33: Other Diagnostics (Diagnostic) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 34: Hospitals (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 35: Hospitals (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2009-2017
TABLE 36: Hospitals (End-Use) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 37: Ambulatory Surgical Centers (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025
TABLE 38: Ambulatory Surgical Centers (End-Use) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017
TABLE 39: Ambulatory Surgical Centers (End-Use) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025
TABLE 40: Other End-Uses (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025
TABLE 41: Other End-Uses (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
TABLE 42: Other End-Uses (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Colorectal Cancer Therapeutics Market Share (in %) by Company: 2019 & 2025
TABLE 43: United States Colorectal Cancer Therapeutics Market Estimates and Projections in US$ Million by Treatment: 2018 to 2025
TABLE 44: Colorectal Cancer Therapeutics Market in the United States by Treatment: A Historic Review in US$ Million for 2009-2017
TABLE 45: United States Colorectal Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 46: United States Colorectal Cancer Therapeutics Market Estimates and Projections in US$ Million by Diagnostic: 2018 to 2025
TABLE 47: Colorectal Cancer Therapeutics Market in the United States by Diagnostic: A Historic Review in US$ Million for 2009-2017
TABLE 48: United States Colorectal Cancer Therapeutics Market Share Breakdown by Diagnostic: 2009 VS 2019 VS 2025
TABLE 49: United States Colorectal Cancer Therapeutics Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
TABLE 50: Colorectal Cancer Therapeutics Historic Demand Patterns in the United States by End-Use in US$ Million for 2009-2017
TABLE 51: Colorectal Cancer Therapeutics Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025
CANADA
TABLE 52: Canadian Colorectal Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Treatment: 2018 to 2025
TABLE 53: Canadian Colorectal Cancer Therapeutics Historic Market Review by Treatment in US$ Million: 2009-2017
TABLE 54: Colorectal Cancer Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
TABLE 55: Canadian Colorectal Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Diagnostic: 2018 to 2025
TABLE 56: Canadian Colorectal Cancer Therapeutics Historic Market Review by Diagnostic in US$ Million: 2009-2017
TABLE 57: Colorectal Cancer Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Diagnostic for 2009, 2019, and 2025
TABLE 58: Canadian Colorectal Cancer Therapeutics Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
TABLE 59: Colorectal Cancer Therapeutics Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
TABLE 60: Canadian Colorectal Cancer Therapeutics Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
JAPAN
TABLE 61: Japanese Market for Colorectal Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Treatment for the Period 2018-2025
TABLE 62: Colorectal Cancer Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Treatment for the Period 2009-2017
TABLE 63: Japanese Colorectal Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
TABLE 64: Japanese Market for Colorectal Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Diagnostic for the Period 2018-2025
TABLE 65: Colorectal Cancer Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Diagnostic for the Period 2009-2017
TABLE 66: Japanese Colorectal Cancer Therapeutics Market Share Analysis by Diagnostic: 2009 VS 2019 VS 2025
TABLE 67: Japanese Demand Estimates and Forecasts for Colorectal Cancer Therapeutics in US$ Million by End-Use: 2018 to 2025
TABLE 68: Japanese Colorectal Cancer Therapeutics Market in US$ Million by End-Use: 2009-2017
TABLE 69: Colorectal Cancer Therapeutics Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025
CHINA
TABLE 70: Chinese Colorectal Cancer Therapeutics Market Growth Prospects in US$ Million by Treatment for the Period 2018-2025
TABLE 71: Colorectal Cancer Therapeutics Historic Market Analysis in China in US$ Million by Treatment: 2009-2017
TABLE 72: Chinese Colorectal Cancer Therapeutics Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 73: Chinese Colorectal Cancer Therapeutics Market Growth Prospects in US$ Million by Diagnostic for the Period 2018-2025
TABLE 74: Colorectal Cancer Therapeutics Historic Market Analysis in China in US$ Million by Diagnostic: 2009-2017
TABLE 75: Chinese Colorectal Cancer Therapeutics Market by Diagnostic: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 76: Chinese Demand for Colorectal Cancer Therapeutics in US$ Million by End-Use: 2018 to 2025
TABLE 77: Colorectal Cancer Therapeutics Market Review in China in US$ Million by End-Use: 2009-2017
TABLE 78: Chinese Colorectal Cancer Therapeutics Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
EUROPE
Market Facts & Figures
European Colorectal Cancer Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
TABLE 79: European Colorectal Cancer Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025
TABLE 80: Colorectal Cancer Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
TABLE 81: European Colorectal Cancer Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
TABLE 82: European Colorectal Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Treatment: 2018-2025
TABLE 83: Colorectal Cancer Therapeutics Market in Europe in US$ Million by Treatment: A Historic Review for the Period 2009-2017
TABLE 84: European Colorectal Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 85: European Colorectal Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Diagnostic: 2018-2025
TABLE 86: Colorectal Cancer Therapeutics Market in Europe in US$ Million by Diagnostic: A Historic Review for the Period 2009-2017
TABLE 87: European Colorectal Cancer Therapeutics Market Share Breakdown by Diagnostic: 2009 VS 2019 VS 2025
TABLE 88: European Colorectal Cancer Therapeutics Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
TABLE 89: Colorectal Cancer Therapeutics Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
TABLE 90: European Colorectal Cancer Therapeutics Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
FRANCE
TABLE 91: Colorectal Cancer Therapeutics Market in France by Treatment: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 92: French Colorectal Cancer Therapeutics Historic Market Scenario in US$ Million by Treatment: 2009-2017
TABLE 93: French Colorectal Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
TABLE 94: Colorectal Cancer Therapeutics Market in France by Diagnostic: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 95: French Colorectal Cancer Therapeutics Historic Market Scenario in US$ Million by Diagnostic: 2009-2017
TABLE 96: French Colorectal Cancer Therapeutics Market Share Analysis by Diagnostic: 2009 VS 2019 VS 2025
TABLE 97: Colorectal Cancer Therapeutics Quantitative Demand Analysis in France in US$ Million by End-Use: 2018-2025
TABLE 98: French Colorectal Cancer Therapeutics Historic Market Review in US$ Million by End-Use: 2009-2017
TABLE 99: French Colorectal Cancer Therapeutics Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
GERMANY
TABLE 100: Colorectal Cancer Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Treatment for the Period 2018-2025
TABLE 101: German Colorectal Cancer Therapeutics Historic Market Analysis in US$ Million by Treatment: 2009-2017
TABLE 102: German Colorectal Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 103: Colorectal Cancer Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Diagnostic for the Period 2018-2025
TABLE 104: German Colorectal Cancer Therapeutics Historic Market Analysis in US$ Million by Diagnostic: 2009-2017
TABLE 105: German Colorectal Cancer Therapeutics Market Share Breakdown by Diagnostic: 2009 VS 2019 VS 2025
TABLE 106: Colorectal Cancer Therapeutics Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025
TABLE 107: German Colorectal Cancer Therapeutics Market in Retrospect in US$ Million by End-Use: 2009-2017
TABLE 108: Colorectal Cancer Therapeutics Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025
ITALY
TABLE 109: Italian Colorectal Cancer Therapeutics Market Growth Prospects in US$ Million by Treatment for the Period 2018-2025
TABLE 110: Colorectal Cancer Therapeutics Historic Market Analysis in Italy in US$ Million by Treatment: 2009-2017
TABLE 111: Italian Colorectal Cancer Therapeutics Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 112: Italian Colorectal Cancer Therapeutics Market Growth Prospects in US$ Million by Diagnostic for the Period 2018-2025
TABLE 113: Colorectal Cancer Therapeutics Historic Market Analysis in Italy in US$ Million by Diagnostic: 2009-2017
TABLE 114: Italian Colorectal Cancer Therapeutics Market by Diagnostic: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 115: Italian Demand for Colorectal Cancer Therapeutics in US$ Million by End-Use: 2018 to 2025
TABLE 116: Colorectal Cancer Therapeutics Market Review in Italy in US$ Million by End-Use: 2009-2017
TABLE 117: Italian Colorectal Cancer Therapeutics Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
UNITED KINGDOM
TABLE 118: United Kingdom Market for Colorectal Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Treatment for the Period 2018-2025
TABLE 119: Colorectal Cancer Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Treatment for the Period 2009-2017
TABLE 120: United Kingdom Colorectal Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
TABLE 121: United Kingdom Market for Colorectal Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Diagnostic for the Period 2018-2025
TABLE 122: Colorectal Cancer Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Diagnostic for the Period 2009-2017
TABLE 123: United Kingdom Colorectal Cancer Therapeutics Market Share Analysis by Diagnostic: 2009 VS 2019 VS 2025
TABLE 124: United Kingdom Demand Estimates and Forecasts for Colorectal Cancer Therapeutics in US$ Million by End-Use: 2018 to 2025
TABLE 125: United Kingdom Colorectal Cancer Therapeutics Market in US$ Million by End-Use: 2009-2017
TABLE 126: Colorectal Cancer Therapeutics Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025
SPAIN
TABLE 127: Spanish Colorectal Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Treatment: 2018 to 2025
TABLE 128: Spanish Colorectal Cancer Therapeutics Historic Market Review by Treatment in US$ Million: 2009-2017
TABLE 129: Colorectal Cancer Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
TABLE 130: Spanish Colorectal Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Diagnostic: 2018 to 2025
TABLE 131: Spanish Colorectal Cancer Therapeutics Historic Market Review by Diagnostic in US$ Million: 2009-2017
TABLE 132: Colorectal Cancer Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Diagnostic for 2009, 2019, and 2025
TABLE 133: Spanish Colorectal Cancer Therapeutics Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
TABLE 134: Colorectal Cancer Therapeutics Market in Spain: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
TABLE 135: Spanish Colorectal Cancer Therapeutics Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
RUSSIA
TABLE 136: Russian Colorectal Cancer Therapeutics Market Estimates and Projections in US$ Million by Treatment: 2018 to 2025
TABLE 137: Colorectal Cancer Therapeutics Market in Russia by Treatment: A Historic Review in US$ Million for 2009-2017
TABLE 138: Russian Colorectal Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 139: Russian Colorectal Cancer Therapeutics Market Estimates and Projections in US$ Million by Diagnostic: 2018 to 2025
TABLE 140: Colorectal Cancer Therapeutics Market in Russia by Diagnostic: A Historic Review in US$ Million for 2009-2017
TABLE 141: Russian Colorectal Cancer Therapeutics Market Share Breakdown by Diagnostic: 2009 VS 2019 VS 2025
TABLE 142: Russian Colorectal Cancer Therapeutics Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
TABLE 143: Colorectal Cancer Therapeutics Historic Demand Patterns in Russia by End-Use in US$ Million for 2009-2017
TABLE 144: Colorectal Cancer Therapeutics Market Share Breakdown in Russia by End-Use: 2009 VS 2019 VS 2025
REST OF EUROPE
TABLE 145: Rest of Europe Colorectal Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Treatment: 2018-2025
TABLE 146: Colorectal Cancer Therapeutics Market in Rest of Europe in US$ Million by Treatment: A Historic Review for the Period 2009-2017
TABLE 147: Rest of Europe Colorectal Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 148: Rest of Europe Colorectal Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Diagnostic: 2018-2025
TABLE 149: Colorectal Cancer Therapeutics Market in Rest of Europe in US$ Million by Diagnostic: A Historic Review for the Period 2009-2017
TABLE 150: Rest of Europe Colorectal Cancer Therapeutics Market Share Breakdown by Diagnostic: 2009 VS 2019 VS 2025
TABLE 151: Rest of Europe Colorectal Cancer Therapeutics Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
TABLE 152: Colorectal Cancer Therapeutics Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
TABLE 153: Rest of Europe Colorectal Cancer Therapeutics Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
ASIA-PACIFIC
TABLE 154: Asia-Pacific Colorectal Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 155: Colorectal Cancer Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
TABLE 156: Asia-Pacific Colorectal Cancer Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
TABLE 157: Colorectal Cancer Therapeutics Market in Asia-Pacific by Treatment: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 158: Asia-Pacific Colorectal Cancer Therapeutics Historic Market Scenario in US$ Million by Treatment: 2009-2017
TABLE 159: Asia-Pacific Colorectal Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
TABLE 160: Colorectal Cancer Therapeutics Market in Asia-Pacific by Diagnostic: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 161: Asia-Pacific Colorectal Cancer Therapeutics Historic Market Scenario in US$ Million by Diagnostic: 2009-2017
TABLE 162: Asia-Pacific Colorectal Cancer Therapeutics Market Share Analysis by Diagnostic: 2009 VS 2019 VS 2025
TABLE 163: Colorectal Cancer Therapeutics Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025
TABLE 164: Asia-Pacific Colorectal Cancer Therapeutics Historic Market Review in US$ Million by End-Use: 2009-2017
TABLE 165: Asia-Pacific Colorectal Cancer Therapeutics Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
AUSTRALIA
TABLE 166: Colorectal Cancer Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Treatment for the Period 2018-2025
TABLE 167: Australian Colorectal Cancer Therapeutics Historic Market Analysis in US$ Million by Treatment: 2009-2017
TABLE 168: Australian Colorectal Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 169: Colorectal Cancer Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Diagnostic for the Period 2018-2025
TABLE 170: Australian Colorectal Cancer Therapeutics Historic Market Analysis in US$ Million by Diagnostic: 2009-2017
TABLE 171: Australian Colorectal Cancer Therapeutics Market Share Breakdown by Diagnostic: 2009 VS 2019 VS 2025
TABLE 172: Colorectal Cancer Therapeutics Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025
TABLE 173: Australian Colorectal Cancer Therapeutics Market in Retrospect in US$ Million by End-Use: 2009-2017
TABLE 174: Colorectal Cancer Therapeutics Market Share Distribution in Australia by End-Use: 2009 VS 2019 VS 2025
INDIA
TABLE 175: Indian Colorectal Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Treatment: 2018 to 2025
TABLE 176: Indian Colorectal Cancer Therapeutics Historic Market Review by Treatment in US$ Million: 2009-2017
TABLE 177: Colorectal Cancer Therapeutics Market in India: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
TABLE 178: Indian Colorectal Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Diagnostic: 2018 to 2025
TABLE 179: Indian Colorectal Cancer Therapeutics Historic Market Review by Diagnostic in US$ Million: 2009-2017
TABLE 180: Colorectal Cancer Therapeutics Market in India: Percentage Share Breakdown of Sales by Diagnostic for 2009, 2019, and 2025
TABLE 181: Indian Colorectal Cancer Therapeutics Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
TABLE 182: Colorectal Cancer Therapeutics Market in India: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
TABLE 183: Indian Colorectal Cancer Therapeutics Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
SOUTH KOREA
TABLE 184: Colorectal Cancer Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Treatment for the Period 2018-2025
TABLE 185: South Korean Colorectal Cancer Therapeutics Historic Market Analysis in US$ Million by Treatment: 2009-2017
TABLE 186: Colorectal Cancer Therapeutics Market Share Distribution in South Korea by Treatment: 2009 VS 2019 VS 2025
TABLE 187: Colorectal Cancer Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Diagnostic for the Period 2018-2025
TABLE 188: South Korean Colorectal Cancer Therapeutics Historic Market Analysis in US$ Million by Diagnostic: 2009-2017
TABLE 189: Colorectal Cancer Therapeutics Market Share Distribution in South Korea by Diagnostic: 2009 VS 2019 VS 2025
TABLE 190: Colorectal Cancer Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2018-2025
TABLE 191: South Korean Colorectal Cancer Therapeutics Historic Market Analysis in US$ Million by End-Use: 2009-2017
TABLE 192: Colorectal Cancer Therapeutics Market Share Distribution in South Korea by End-Use: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
TABLE 193: Rest of Asia-Pacific Market for Colorectal Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Treatment for the Period 2018-2025
TABLE 194: Colorectal Cancer Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Treatment for the Period 2009-2017
TABLE 195: Rest of Asia-Pacific Colorectal Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
TABLE 196: Rest of Asia-Pacific Market for Colorectal Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Diagnostic for the Period 2018-2025
TABLE 197: Colorectal Cancer Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Diagnostic for the Period 2009-2017
TABLE 198: Rest of Asia-Pacific Colorectal Cancer Therapeutics Market Share Analysis by Diagnostic: 2009 VS 2019 VS 2025
TABLE 199: Rest of Asia-Pacific Demand Estimates and Forecasts for Colorectal Cancer Therapeutics in US$ Million by End-Use: 2018 to 2025
TABLE 200: Rest of Asia-Pacific Colorectal Cancer Therapeutics Market in US$ Million by End-Use: 2009-2017
TABLE 201: Colorectal Cancer Therapeutics Market Share Shift in Rest of Asia-Pacific by End-Use: 2009 VS 2019 VS 2025
LATIN AMERICA
TABLE 202: Latin American Colorectal Cancer Therapeutics Market Trends by Region/Country in US$ Million: 2018-2025
TABLE 203: Colorectal Cancer Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
TABLE 204: Latin American Colorectal Cancer Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
TABLE 205: Latin American Colorectal Cancer Therapeutics Market Growth Prospects in US$ Million by Treatment for the Period 2018-2025
TABLE 206: Colorectal Cancer Therapeutics Historic Market Analysis in Latin America in US$ Million by Treatment: 2009-2017
TABLE 207: Latin American Colorectal Cancer Therapeutics Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 208: Latin American Colorectal Cancer Therapeutics Market Growth Prospects in US$ Million by Diagnostic for the Period 2018-2025
TABLE 209: Colorectal Cancer Therapeutics Historic Market Analysis in Latin America in US$ Million by Diagnostic: 2009-2017
TABLE 210: Latin American Colorectal Cancer Therapeutics Market by Diagnostic: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 211: Latin American Demand for Colorectal Cancer Therapeutics in US$ Million by End-Use: 2018 to 2025
TABLE 212: Colorectal Cancer Therapeutics Market Review in Latin America in US$ Million by End-Use: 2009-2017
TABLE 213: Latin American Colorectal Cancer Therapeutics Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
ARGENTINA
TABLE 214: Argentinean Colorectal Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Treatment: 2018-2025
TABLE 215: Colorectal Cancer Therapeutics Market in Argentina in US$ Million by Treatment: A Historic Review for the Period 2009-2017
TABLE 216: Argentinean Colorectal Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 217: Argentinean Colorectal Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Diagnostic: 2018-2025
TABLE 218: Colorectal Cancer Therapeutics Market in Argentina in US$ Million by Diagnostic: A Historic Review for the Period 2009-2017
TABLE 219: Argentinean Colorectal Cancer Therapeutics Market Share Breakdown by Diagnostic: 2009 VS 2019 VS 2025
TABLE 220: Argentinean Colorectal Cancer Therapeutics Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
TABLE 221: Colorectal Cancer Therapeutics Market in Argentina: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
TABLE 222: Argentinean Colorectal Cancer Therapeutics Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
BRAZIL
TABLE 223: Colorectal Cancer Therapeutics Market in Brazil by Treatment: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 224: Brazilian Colorectal Cancer Therapeutics Historic Market Scenario in US$ Million by Treatment: 2009-2017
TABLE 225: Brazilian Colorectal Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
TABLE 226: Colorectal Cancer Therapeutics Market in Brazil by Diagnostic: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 227: Brazilian Colorectal Cancer Therapeutics Historic Market Scenario in US$ Million by Diagnostic: 2009-2017
TABLE 228: Brazilian Colorectal Cancer Therapeutics Market Share Analysis by Diagnostic: 2009 VS 2019 VS 2025
TABLE 229: Colorectal Cancer Therapeutics Quantitative Demand Analysis in Brazil in US$ Million by End-Use: 2018-2025
TABLE 230: Brazilian Colorectal Cancer Therapeutics Historic Market Review in US$ Million by End-Use: 2009-2017
TABLE 231: Brazilian Colorectal Cancer Therapeutics Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
MEXICO
TABLE 232: Colorectal Cancer Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Treatment for the Period 2018-2025
TABLE 233: Mexican Colorectal Cancer Therapeutics Historic Market Analysis in US$ Million by Treatment: 2009-2017
TABLE 234: Mexican Colorectal Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 235: Colorectal Cancer Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Diagnostic for the Period 2018-2025
TABLE 236: Mexican Colorectal Cancer Therapeutics Historic Market Analysis in US$ Million by Diagnostic: 2009-2017
TABLE 237: Mexican Colorectal Cancer Therapeutics Market Share Breakdown by Diagnostic: 2009 VS 2019 VS 2025
TABLE 238: Colorectal Cancer Therapeutics Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025
TABLE 239: Mexican Colorectal Cancer Therapeutics Market in Retrospect in US$ Million by End-Use: 2009-2017
TABLE 240: Colorectal Cancer Therapeutics Market Share Distribution in Mexico by End-Use: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
TABLE 241: Rest of Latin America Colorectal Cancer Therapeutics Market Estimates and Projections in US$ Million by Treatment: 2018 to 2025
TABLE 242: Colorectal Cancer Therapeutics Market in Rest of Latin America by Treatment: A Historic Review in US$ Million for 2009-2017
TABLE 243: Rest of Latin America Colorectal Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 244: Rest of Latin America Colorectal Cancer Therapeutics Market Estimates and Projections in US$ Million by Diagnostic: 2018 to 2025
TABLE 245: Colorectal Cancer Therapeutics Market in Rest of Latin America by Diagnostic: A Historic Review in US$ Million for 2009-2017
TABLE 246: Rest of Latin America Colorectal Cancer Therapeutics Market Share Breakdown by Diagnostic: 2009 VS 2019 VS 2025
TABLE 247: Rest of Latin America Colorectal Cancer Therapeutics Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
TABLE 248: Colorectal Cancer Therapeutics Historic Demand Patterns in Rest of Latin America by End-Use in US$ Million for 2009-2017
TABLE 249: Colorectal Cancer Therapeutics Market Share Breakdown in Rest of Latin America by End-Use: 2009 VS 2019 VS 2025
MIDDLE EAST
TABLE 250: The Middle East Colorectal Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 251: Colorectal Cancer Therapeutics Market in the Middle East by Region/Country in US$ Million: 2009-2017
TABLE 252: The Middle East Colorectal Cancer Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025
TABLE 253: The Middle East Colorectal Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Treatment: 2018 to 2025
TABLE 254: The Middle East Colorectal Cancer Therapeutics Historic Market by Treatment in US$ Million: 2009-2017
TABLE 255: Colorectal Cancer Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
TABLE 256: The Middle East Colorectal Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Diagnostic: 2018 to 2025
TABLE 257: The Middle East Colorectal Cancer Therapeutics Historic Market by Diagnostic in US$ Million: 2009-2017
TABLE 258: Colorectal Cancer Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Diagnostic for 2009, 2019, and 2025
TABLE 259: The Middle East Colorectal Cancer Therapeutics Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
TABLE 260: Colorectal Cancer Therapeutics Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
TABLE 261: The Middle East Colorectal Cancer Therapeutics Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
IRAN
TABLE 262: Iranian Market for Colorectal Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Treatment for the Period 2018-2025
TABLE 263: Colorectal Cancer Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Treatment for the Period 2009-2017
TABLE 264: Iranian Colorectal Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
TABLE 265: Iranian Market for Colorectal Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Million by Diagnostic for the Period 2018-2025
TABLE 266: Colorectal Cancer Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Diagnostic for the Period 2009-2017
TABLE 267: Iranian Colorectal Cancer Therapeutics Market Share Analysis by Diagnostic: 2009 VS 2019 VS 2025
TABLE 268: Iranian Demand Estimates and Forecasts for Colorectal Cancer Therapeutics in US$ Million by End-Use: 2018 to 2025
TABLE 269: Iranian Colorectal Cancer Therapeutics Market in US$ Million by End-Use: 2009-2017
TABLE 270: Colorectal Cancer Therapeutics Market Share Shift in Iran by End-Use: 2009 VS 2019 VS 2025
ISRAEL
TABLE 271: Israeli Colorectal Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Treatment: 2018-2025
TABLE 272: Colorectal Cancer Therapeutics Market in Israel in US$ Million by Treatment: A Historic Review for the Period 2009-2017
TABLE 273: Israeli Colorectal Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 274: Israeli Colorectal Cancer Therapeutics Market Estimates and Forecasts in US$ Million by Diagnostic: 2018-2025
TABLE 275: Colorectal Cancer Therapeutics Market in Israel in US$ Million by Diagnostic: A Historic Review for the Period 2009-2017
TABLE 276: Israeli Colorectal Cancer Therapeutics Market Share Breakdown by Diagnostic: 2009 VS 2019 VS 2025
TABLE 277: Israeli Colorectal Cancer Therapeutics Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
TABLE 278: Colorectal Cancer Therapeutics Market in Israel: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
TABLE 279: Israeli Colorectal Cancer Therapeutics Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
SAUDI ARABIA
TABLE 280: Saudi Arabian Colorectal Cancer Therapeutics Market Growth Prospects in US$ Million by Treatment for the Period 2018-2025
TABLE 281: Colorectal Cancer Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Treatment: 2009-2017
TABLE 282: Saudi Arabian Colorectal Cancer Therapeutics Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 283: Saudi Arabian Colorectal Cancer Therapeutics Market Growth Prospects in US$ Million by Diagnostic for the Period 2018-2025
TABLE 284: Colorectal Cancer Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Diagnostic: 2009-2017
TABLE 285: Saudi Arabian Colorectal Cancer Therapeutics Market by Diagnostic: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 286: Saudi Arabian Demand for Colorectal Cancer Therapeutics in US$ Million by End-Use: 2018 to 2025
TABLE 287: Colorectal Cancer Therapeutics Market Review in Saudi Arabia in US$ Million by End-Use: 2009-2017
TABLE 288: Saudi Arabian Colorectal Cancer Therapeutics Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
UNITED ARAB EMIRATES
TABLE 289: Colorectal Cancer Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Treatment for the Period 2018-2025
TABLE 290: United Arab Emirates Colorectal Cancer Therapeutics Historic Market Analysis in US$ Million by Treatment: 2009-2017
TABLE 291: Colorectal Cancer Therapeutics Market Share Distribution in United Arab Emirates by Treatment: 2009 VS 2019 VS 2025
TABLE 292: Colorectal Cancer Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Diagnostic for the Period 2018-2025
TABLE 293: United Arab Emirates Colorectal Cancer Therapeutics Historic Market Analysis in US$ Million by Diagnostic: 2009-2017
TABLE 294: Colorectal Cancer Therapeutics Market Share Distribution in United Arab Emirates by Diagnostic: 2009 VS 2019 VS 2025
TABLE 295: Colorectal Cancer Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2018-2025
TABLE 296: United Arab Emirates Colorectal Cancer Therapeutics Historic Market Analysis in US$ Million by End-Use: 2009-2017
TABLE 297: Colorectal Cancer Therapeutics Market Share Distribution in United Arab Emirates by End-Use: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
TABLE 298: Colorectal Cancer Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Treatment for the Period 2018-2025
TABLE 299: Rest of Middle East Colorectal Cancer Therapeutics Historic Market Analysis in US$ Million by Treatment: 2009-2017
TABLE 300: Rest of Middle East Colorectal Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 301: Colorectal Cancer Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Diagnostic for the Period 2018-2025
TABLE 302: Rest of Middle East Colorectal Cancer Therapeutics Historic Market Analysis in US$ Million by Diagnostic: 2009-2017
TABLE 303: Rest of Middle East Colorectal Cancer Therapeutics Market Share Breakdown by Diagnostic: 2009 VS 2019 VS 2025
TABLE 304: Colorectal Cancer Therapeutics Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025
TABLE 305: Rest of Middle East Colorectal Cancer Therapeutics Market in Retrospect in US$ Million by End-Use: 2009-2017
TABLE 306: Colorectal Cancer Therapeutics Market Share Distribution in Rest of Middle East by End-Use: 2009 VS 2019 VS 2025
AFRICA
TABLE 307: African Colorectal Cancer Therapeutics Market Estimates and Projections in US$ Million by Treatment: 2018 to 2025
TABLE 308: Colorectal Cancer Therapeutics Market in Africa by Treatment: A Historic Review in US$ Million for 2009-2017
TABLE 309: African Colorectal Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
TABLE 310: African Colorectal Cancer Therapeutics Market Estimates and Projections in US$ Million by Diagnostic: 2018 to 2025
TABLE 311: Colorectal Cancer Therapeutics Market in Africa by Diagnostic: A Historic Review in US$ Million for 2009-2017
TABLE 312: African Colorectal Cancer Therapeutics Market Share Breakdown by Diagnostic: 2009 VS 2019 VS 2025
TABLE 313: African Colorectal Cancer Therapeutics Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
TABLE 314: Colorectal Cancer Therapeutics Historic Demand Patterns in Africa by End-Use in US$ Million for 2009-2017
TABLE 315: Colorectal Cancer Therapeutics Market Share Breakdown in Africa by End-Use: 2009 VS 2019 VS 2025
IV. COMPETITION
AMGEN
BAYER AG
F. HOFFMANN-LA ROCHE AG
MERCK KGAA
NOVARTIS INTERNATIONAL AG
SPECTRUM PHARMACEUTICALS
V. CURATED RESEARCH

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook